Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Marijn Verhoef joins the Panmure House Dialogues on AMR

Marijn Verhoef, Director of Private Sector Engagement at the Access to Medicine Foundation, will attend the first Panmure House Dialogues focused on the economic impact of antimicrobial resistance (AMR), where he will share insights from the Foundation’s AMR Programme.

Date

06 November 2025

Location

Edinburgh

The Panmure House Dialogues will bring together leaders in policymaking, the pharmaceutical industry, biotechnology, finance and academia to discuss the economic impact of antimicrobial resistance (AMR), and strategies for mitigating drug resistance that balance public health priorities with investment feasability. 

In the first session, panellists will discuss how to attract more investors to fund the protection of antimicrobial products’ effectiveness and the need for cross-sector coordination in creating strategies around this goal. 

The dialogue chairs will include Adam Dixon, chair of Adam Smith at Adam Smith’s Panmure House, part of Edinburgh Business School, and Lucy Naga, postdoctoral researcher in Economics at Heriot-Watt University, who manages the Panmure House Dialogues. 

Marijn Verhoef, Director of Private Sector Engagement at the Access to Medicine Foundation, will attend the meeting. He plans to highlight the importance of allocating resources to the research and development of new antimicrobial products, drawing insights from the Access to Medicine Foundation’s AMR Research Programme.  

Insights from the dialogues will be used to create a series of white papers for guiding policy and investment communities’ strategies. 

About the Panmure House Dialogues 

The Panmure House Dialogues are a new series of events set to take place at the Adam Smith House in Edenborough, providing a platform for experts to discuss the impact of AMR to the global economy, as well as strategies for mitigating against it through investment. 

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch
News

New methodology paves the way for the Foundation's 2026 AMR Benchmark

28 January 2025
News

More superbugs, fewer drugs. How can pharma companies ensure the handful of promising antimicrobials make it to the frontlines of drug resistance?

23 May 2024
News

What steps are companies taking to help curb AMR by manufacturing responsibly?

22 August 2023

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved